Literature DB >> 3316031

Prior exposure to subimmunogenic amounts of some bacterial lipopolysaccharides induces specific immunological unresponsiveness.

K L Elkins1, P W Stashak, P J Baker.   

Abstract

Pretreatment (priming) of BALB/c mice with a low (subimmunogenic) dose of Escherichia coli O113 lipopolysaccharide (LPS) generates immunological memory 7 to 30 days later; the direct (immunoglobulin M) plaque-forming cell (PFC) responses produced after subsequent immunization with an optimal dose are 4 to 20 times greater than those of unprimed mice. By contrast, priming with a low dose of E. coli O55 LPS, followed by immunization with an optimally immunogenic dose 2 to 30 days later, resulted in a significantly reduced antibody response. Similar results were obtained with Serratia marcescens LPS. Dose-response studies indicated that such unresponsiveness is antigen specific and could be induced with subimmunogenic amounts of LPS. Priming reduced the magnitude of the PFC response to all immunizing doses of LPS tested. Unresponsiveness is not due to (i) an alteration in the time course of the PFC response or to (ii) a change in the isotype of the anti-LPS antibody produced after priming and immunization.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3316031      PMCID: PMC260032          DOI: 10.1128/iai.55.12.3085-3092.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Characteristics of amplifier T cells involved in the antibody response to the capsular polysaccharide of type III Streptococcus pneumoniae.

Authors:  C E Taylor; P W Stashak; J Chiang; W M Leiserson; G Caldes; B Prescott; P J Baker
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

2.  Direct evidence for the involvement of T suppressor cells in the expression of low-dose paralysis to type III pneumococcal polysaccharide.

Authors:  P J Baker; D F Amsbaugh; P W Stashak; G Caldes; B Prescott
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

Review 3.  New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development.

Authors:  M M Levine; J B Kaper; R E Black; M L Clements
Journal:  Microbiol Rev       Date:  1983-12

4.  Regulation of the antibody response to pneumococcal polysaccharide by thymus-derived cells.

Authors:  P J Baker; D F Amsbaugh; P W Stashak; G Caldes; B Prescott
Journal:  Rev Infect Dis       Date:  1981 Mar-Apr

5.  Study on B-memory generation by Tnp-Ficoll: induction but not expression is observed among various inbred mouse strains.

Authors:  M A Le Moal; J H Colle; P Truffa-Bachi
Journal:  Cell Immunol       Date:  1984-08       Impact factor: 4.868

6.  Endotoxin-induced T lymphocyte proliferation.

Authors:  S N Vogel; M L Hilfiker; M J Caulfield
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

7.  Cellular responses to bacterial lipopolysaccharide: T cells recognize LPS determinants.

Authors:  E C Milner; J A Rudbach; K B Voneschen
Journal:  Scand J Immunol       Date:  1983-07       Impact factor: 3.487

8.  Induction of splenic T cell proliferation by lipid A in mice immunized with sheep red blood cells.

Authors:  A Mita; H Ohta; T Mita
Journal:  J Immunol       Date:  1982-04       Impact factor: 5.422

9.  Igh-V or closely linked gene(s) control immunological memory to a thymus-independent antigen.

Authors:  J H Colle; I Motta; B Shidani; P Truffa-Bachi
Journal:  Nature       Date:  1983-02-03       Impact factor: 49.962

10.  Antibody response of immunodeficient (xid) CBA/N mice to Escherichia coli 0113 lipopolysaccharide, a thymus-independent antigen.

Authors:  J R Hiernaux; J M Jones; J A Rudbach; F Rollwagen; P J Baker
Journal:  J Exp Med       Date:  1983-04-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Regulation of magnitude of antibody response to bacterial polysaccharide antigens by thymus-derived lymphocytes.

Authors:  P J Baker
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

2.  T-cell modulation of the antibody response to bacterial polysaccharide antigens.

Authors:  C E Taylor; R Bright
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

3.  Protective immunization against experimental Bacteroides (Porphyromonas) gingivalis infection.

Authors:  P B Chen; L B Davern; R Schifferle; J J Zambon
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

4.  Specific immunological unresponsiveness to bacterial lipopolysaccharides develops in a cyclic manner.

Authors:  K L Elkins; P W Stashak; P J Baker
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

5.  Characterization of the immunodeficiency of RIIIS/J mice: immune response to polysaccharide antigens.

Authors:  J R Hiernaux; P J Baker; S J McEvoy; P W Stashak; M B Fauntleroy; E A Goidl
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

6.  Molecular structures that influence the immunomodulatory properties of the lipid A and inner core region oligosaccharides of bacterial lipopolysaccharides.

Authors:  P J Baker; T Hraba; C E Taylor; P W Stashak; M B Fauntleroy; U Zähringer; K Takayama; T R Sievert; X Hronowski; R J Cotter
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.